TrialAIDS research and human retroviruses2020

Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials.

Erkki Lathouwers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.